Clinical Trials Directory

Trials / Terminated

TerminatedNCT05795946

Standard Process Heart and Gut Health Study

Effects of a Whole Food Based Nutritional Formulation on Trimethylamine N-oxide and Cardiometabolic Endpoints in Healthy Adults.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Standard Process Inc. · Industry
Sex
All
Age
25 Years – 80 Years
Healthy volunteers
Accepted

Summary

Standard Process Heart and Gut Health Study

Detailed description

This prospective pilot clinical study will screen 45 healthy participants regularly consuming omnivorous diet (full fat dairy, red meat, eggs, fish) and have elevated serum Trimethyl amine N-oxide (TMAO) levels. Trimethylamine N-oxide (TMAO) is a gut microbiota derived dietary metabolite which is emerging as a significant and independent predictor of cardiovascular disease (CVD) risk mainly through inflammation and oxidative stress pathways. Long term consumption of animal products elevates TMAO levels due to its abundance of TMAO precursors: choline and L-carnitine. As diet plays a key role in altering the microbial composition and subsequent TMAO levels, it is important to investigate if whole food based nutritional formulations can provide the necessary support required to manage TMAO levels and hence, positively impact cardiometabolic endpoints. Towards this end both B and D vitamins have been shown to influence the levels of circulating TMAO while maintaining a healthy gut microenvironment. This pilot study aims to explore the modulation of TMAO response in healthy adults after supplementation with a whole food matrix-based B vitamins formulation alone, and in combination with vitamin D. The assessments will be compared to the diet only control group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhole food-based B and D vitaminsLooking at whole food-based B and D vitamins to reduce TMAO levels and if this can modulate gut diversity

Timeline

Start date
2023-04-15
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-04-03
Last updated
2025-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05795946. Inclusion in this directory is not an endorsement.